Moderately bullish activity in Moderna (MRNA), with shares up 15c, or 0.53%, near $28.39. Options volume roughly in line with average with 51k contracts traded and calls leading puts for a put/call ratio of 0.24, compared to a typical level near 0.62. Implied volatility (IV30) is higher by 6.0 points near 64.71,in the bottom quartile of the past year, suggesting an expected daily move of $1.16. Put-call skew steepened, indicating increased demand for downside protection.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- FDA probe into COVID vaccines includes adults, Bloomberg reports
- FDA to investigate COVID vaccine safety across age groups
- Moderna’s Growth Prospects: Balancing Revenue Potential and Legal Challenges
- Mixed options sentiment in Moderna with shareslittle changed
- Private Markets: Kalshi announces new funding at $11B valuation